New England Journal of Medicine: Mediterranean Plant Extracts Show Promise in Cancer Prevention

Title: New England Journal of Medicine: Mediterranean Plant Extracts Show Promise in Cancer Prevention

Meta Description: The New England Journal of Medicine highlights the promise of Mediterranean Plant Extracts for cancer prevention. Blue Eyes Biotech provides a range of these functional ingredients.

Article:

A landmark review in The New England Journal of Medicine has brought significant academic credibility to the cancer-preventive properties

of the Mediterranean diet, specifically highlighting the role of specific plant extracts beyond general dietary patterns.

The 2024 publication pointed to robust epidemiological and mechanistic evidence for compounds like oleuropein from olive leaf and

carnosic acid from rosemary. These compounds are recognized for their ability to modulate multiple hallmarks of cancer, including

sustained proliferation, inflammation, and cell death resistance. The review called for more targeted supplementation strategies using

standardized extracts to achieve consistent, therapeutic levels of these bioactive compounds. Blue Eyes Biotech CO., Ltd. answers this

call by offering a curated portfolio of standardized Mediterranean plant extracts. Our Olive Leaf Extract is standardized to 20% oleuropein,

a potent antioxidant and anti-inflammatory agent, while our Rosemary Extract is standardized for carnosic acid, known for its neuroprotective

and anti-proliferative properties. For forward-thinking nutraceutical brands, this represents an opportunity to develop sophisticated,

multi-ingredient formulas based on a globally recognized and scientifically endorsed dietary pattern. Blue Eyes Biotech ensures the authenticity

and potency of these extracts through rigorous sourcing from designated growing regions and advanced analytical testing. By providing

these key Mediterranean ingredients, we enable our partners to create next-generation preventive health products that are grounded in one

of the most respected and evidence-based health paradigms in the world. For a portfolio overview, email [email protected].